Search Results - "De Vernejoul, Mc"

Refine Results
  1. 1
  2. 2
  3. 3

    Osteoporosis in Patients on Long‐Term Home Parenteral Nutrition: A Longitudinal Study by Cohen‐Solal, M, Baudoin, C, Joly, F, Vahedi, K, D'Aoust, L, De Vernejoul, Mc, Messing, B

    Published in Journal of bone and mineral research (01-11-2003)
    “…The prevalence of osteoporosis was investigated in 88 patients with intestinal failure (IF). Osteoporosis was found in 67%, dependent of body mass index and…”
    Get full text
    Journal Article
  4. 4

    BMD Is Reduced in HIV‐Infected Men Irrespective of Treatment by Amiel, C, Ostertag, A, Slama, L, Baudoin, C, N'Guyen, T, Lajeunie, E, Neit‐Ngeilh, L, Rozenbaum, W, De Vernejoul, MC

    Published in Journal of bone and mineral research (01-03-2004)
    “…Osteoporosis has be reported to be a complication of active antiretroviral therapy of HIV infection. We studied 148 HIV‐infected men stratified according to…”
    Get full text
    Journal Article
  5. 5

    Arterial calcifications and bone histomorphometry in end-stage renal disease by LONDON, Gérard M, MARTY, Caroline, MARCHAIS, Sylvain J, GUERIN, Alain P, METIVIER, Fabien, DE VERNEJOUL, Marie-Christine

    “…Arterial calcification (AC) is a common complication of end-stage renal disease (ESRD). The mechanisms responsible are complex, including disturbances of…”
    Get full text
    Journal Article
  6. 6

    Cannabinoid receptor type 2 gene is associated with human osteoporosis by Karsak, Meliha, Cohen-Solal, Martine, Freudenberg, Jan, Ostertag, Agnes, Morieux, Caroline, Kornak, Uwe, Essig, Julia, Erxlebe, Edda, Bab, Itai, Kubisch, Christian, de Vernejoul, Marie-Christine, Zimmer, Andreas

    Published in Human molecular genetics (15-11-2005)
    “…Osteoporosis is one of the most common degenerative diseases. It is characterized by reduced bone mineral density (BMD) with an increased risk for bone…”
    Get full text
    Journal Article
  7. 7

    When, How, and Why a Bone Biopsy Should Be Performed in Patients With Chronic Kidney Disease by Torres, Pablo Ureña, MD, PhD, Bover, Jordi, MD, PhD, Mazzaferro, Sandro, MD, PhD, de Vernejoul, Marie Christine, MD, PhD, Cohen-Solal, Martine, MD, PhD

    Published in Seminars in nephrology (01-11-2014)
    “…Summary In chronic kidney disease the excessive production of parathyroid hormone increases the bone resorption rate and leads to histologic bone signs of…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Strontium ranelate: Dose-dependent effects in established postmenopausal vertebral osteoporosis: A 2-year randomized placebo controlled trial by MEUNIER, P. J, SLOSMAN, D. O, REGINSTER, J. Y, DELMAS, P. D, SEBERTT, J. L, BRANDI, M. L, ALBANESE, C, LORENC, R, PORS-NIELSEN, S, DE VERNEJOUL, M. C, ROCES, A

    “…The aim of the strontium ranelate (SR) for treatment of osteoporosis (STRATOS) trial was to investigate the efficacy and safety of different doses of SR, a…”
    Get full text
    Journal Article Web Resource
  10. 10

    Sclerosing bone disorders by de Vernejoul, Marie-Christine, MD

    “…Sclerosing bone disorders are a diagnostic challenge. However, hereditary sclerosing disorders often have characteristic radiological features that allow their…”
    Get full text
    Journal Article
  11. 11

    Vertebral fractures are associated with increased cortical porosity in iliac crest bone biopsy of men with idiopathic osteoporosis by Ostertag, Agnès, Cohen-Solal, Martine, Audran, Maurice, Legrand, Erick, Marty, Caroline, Chappard, Daniel, de Vernejoul, Marie-Christine

    Published in Bone (New York, N.Y.) (01-03-2009)
    “…Abstract In men, vertebral fractures are poorly associated with bone density, and both cortical and trabecular micro-architectural changes could contribute to…”
    Get full text
    Journal Article
  12. 12

    Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients by Ureña, Pablo, Bernard-Poenaru, Oana, Ostertag, Agnès, Baudoin, Claude, Cohen-Solal, Martine, Cantor, Tom, de Vernejoul, Marie Christine

    Published in Nephrology, dialysis, transplantation (01-11-2003)
    “…Background. End-stage renal disease is often associated with altered bone metabolism. Methods. In order to investigate the determinant factors of bone mineral…”
    Get full text
    Journal Article
  13. 13

    Circulating biochemical markers of bone remodeling in uremic patients by Ureña, Pablo, de Vernejoul, Marie-Christine

    Published in Kidney international (01-06-1999)
    “…Circulating biochemical markers of bone remodeling in uremic patients. Chronic renal failure is often associated with bone disorders, including secondary…”
    Get full text
    Journal Article Conference Proceeding
  14. 14

    Markers of bone remodelling in metabolic bone disease by de Vernejoul, M C

    Published in Drugs & aging (1998)
    “…New specific markers of bone remodelling have been developed that allow the evaluation of bone formation (plasma levels of osteocalcin and bone alkaline…”
    Get full text
    Journal Article
  15. 15

    Severe osteopenia in CFTR-null mice by Dif, Fariel, Marty, Caroline, Baudoin, Claude, de Vernejoul, Marie-Christine, Levi, Giovanni

    Published in Bone (New York, N.Y.) (01-09-2004)
    “…Osteoporosis is a common complication in cystic fibrosis (CF) patients. In this study, we performed a histomorphometric analysis of the bones of a mouse…”
    Get full text
    Journal Article
  16. 16

    LRP5 mutations in osteoporosis-pseudoglioma syndrome and high-bone-mass disorders by Levasseur, Régis, Lacombe, Didier, Christine de Vernejoul, Marie

    Published in Joint, bone, spine : revue du rhumatisme (01-05-2005)
    “…The LDL receptor-related protein 5 (LRP5) is a member of the LDL receptor family, which also includes the VLDL receptor and the apolipoprotein E receptor 2…”
    Get full text
    Journal Article
  17. 17
  18. 18

    LRP5 gene polymorphisms and idiopathic osteoporosis in men by Ferrari, S.L., Deutsch, S., Baudoin, C., Cohen-Solal, M., Ostertag, A., Antonarakis, S.E., Rizzoli, R., de Vernejoul, M.C.

    Published in Bone (New York, N.Y.) (01-12-2005)
    “…Mutations in the low-density lipoprotein receptor-related protein 5 gene ( LRP5) have demonstrated the role of LRP5 in bone mass acquisition. LRP5 variants…”
    Get full text
    Journal Article
  19. 19

    Type II autosomal dominant osteopetrosis (Albers-Schönberg disease): clinical and radiological manifestations in 42 patients by Bénichou, O.D, Laredo, J.D, de Vernejoul, M.C

    Published in Bone (New York, N.Y.) (2000)
    “…Type II autosomal dominant osteopetrosis (ADO II, Albers-Schönberg disease) is a genetic condition characterized by generalized osteosclerosis predominating in…”
    Get full text
    Journal Article
  20. 20

    Polymorphisms in the CLCN7 Gene Modulate Bone Density in Postmenopausal Women and in Patients with Autosomal Dominant Osteopetrosis Type II by Kornak, U., Ostertag, A., Branger, S., Benichou, O., de Vernejoul, M.-C.

    “…Context: Genetic factors are important determinants of bone mineral density (BMD). The fact that mutations in the ClC-7 chloride channel cause autosomal…”
    Get full text
    Journal Article